Real-world Experiences in the Transplantation of Hepatitis C-NAAT-positive Organs.
Julie M SteinbrinkJennifer ByrnsCarl BergMatthew KappusLindsay KingMatthew J EllisScott SanoffRicha AgarwalAdam D DeVoreJohn M ReynoldsMatthew G HartwigCarmelo MilanoDebra SudanEileen K MaziarzJennifer SaulloBarbara D AlexanderCameron R WolfePublished in: Transplantation direct (2023)
One hundred percent of transplant recipients of HCV-NAAT-positive organs ultimately developed SVR without significant adverse effects when HCV antivirals were initiated in the outpatient setting after transplant hospitalization, suggesting that this real-world treatment pathway is a viable option.